Atrovent ipratropium Bromide

This page contains recent news articles, when available, and an overview of Atrovent ipratropium Bromide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Determination That ATROVENT (Ipatropium Bromide) Inhalation ...  -  Oct 1, 2008
...(As requested by the applicant, FDA withdrew approval of NDA 20-228 for ATROVENT (ipratropium bromide) Inhalation Solution in the Federal Register of Trading Markets (press release),

COPD Drugs Linked To Cardiovascular Risk  -  Sep 24, 2008
In a press statement reported by WebMD, Boehringer Ingelheim, a German company that markets Atrovent (ipratropium bromide) and also markets Spiriva Medical News Today,

High Growth Reported for the World Pulmonary Drug Delivery ...  -  Oct 1, 2008
Pulmicort Turbohaler (budesonide), Atrovent (ipratropium bromide), Ventolin (albuterol), Combivent (ipratropium bromide + albuterol sulfate), MarketWatch

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.